See today's BioWorld MedTech
To read the full story, subscribe or sign in.

FDA clears Vuno’s AI-based MRI reading software for early Alzheimer’s detection

Oct. 25, 2023
By Marian (YoonJee) Chu
Vuno Inc. gained a U.S. FDA’s 510(k) clearance for its artificial intelligence (AI)-powered brain quantification device, Vuno Med-Deepbrain, to diagnose possible dementia in patients “even before mild cognitive impairment.”
BioWorld MedTech Regions Regulatory Neurology/psychiatric Diagnostics U.S. FDA